Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood glucose and brain function: interactions with CNS cholinergic systems.

W S Stone1, K L Cottrill, D L Walker

  • 1Department of Psychology, University of Virginia, Charlottesville 22903.

Behavioral and Neural Biology
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic intervention-based biomarkers may reduce heterogeneity and motivate targeted interventions in clinical high risk for psychosis.

Schizophrenia research·2022
Same author

Extracellular levels of glucose in the hippocampus and striatum during maze training for food or water reward in male rats.

Behavioural brain research·2021
Same author

Aging is not equal across memory systems.

Neurobiology of learning and memory·2020
Same author

Attenuation in rats of impairments of memory by scopolamine, a muscarinic receptor antagonist, by mecamylamine, a nicotinic receptor antagonist.

Psychopharmacology·2015
Same author

Advances in quality control: mouse embryo morphokinetics are sensitive markers of in vitro stress.

Human reproduction (Oxford, England)·2013
Same author

Anxiogenic effects of CGRP within the BNST may be mediated by CRF acting at BNST CRFR1 receptors.

Behavioural brain research·2013

Glucose enhances the effects of cholinergic agonists on brain function, influencing locomotor activity and tremors. This suggests circulating glucose levels can modulate central cholinergic activity.

Area of Science:

  • Neuroscience
  • Behavioral Pharmacology

Background:

  • Previous research indicated glucose injections can reduce amnesia and hyperactivity induced by scopolamine, a muscarinic antagonist.
  • The role of glucose in modulating the effects of cholinergic agonists on central nervous system functions remains an area of investigation.

Purpose of the Study:

  • To investigate whether glucose administration augments the behavioral effects induced by physostigmine, a muscarinic agonist.
  • To examine the influence of glucose on physostigmine-induced hyperactivity and tremors.

Main Methods:

  • Experiment I: Determined doses of glucose and physostigmine that did not alter scopolamine-induced hyperactivity independently, then assessed combined effects.
  • Experiment II: Administered varying doses of glucose before physostigmine injections and observed effects on tremor onset and severity over 25 minutes.

Related Experiment Videos

Main Results:

  • Combined glucose-physostigmine injections significantly reduced scopolamine-induced hyperactivity.
  • Glucose (100 mg/kg) facilitated the onset of physostigmine-induced tremors.
  • Glucose (100 and 250 mg/kg) augmented the severity of physostigmine-induced tremors.

Conclusions:

  • Glucose can facilitate the actions of cholinergic agonists on behaviors such as locomotor activity and tremors.
  • These findings support the hypothesis that circulating glucose levels modulate central cholinergic function.
  • The study provides further evidence for the influence of glucose on overall brain function.